Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.74 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.74 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.74 |
| ▸ | HTR2B | P41595 | 1/20 | 0.74 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.74 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.74 |
| ▸ | PTPN11 | Q06124 | 6/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.60 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1274781 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL6575990 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL18140779 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL2047269 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL1005992 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL2044840 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL8859205 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL342176 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL2550439 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL18141371 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0330685-B1 | CHROMOGENIC COPY SYSTEM AND METHODS | Vassiliades, Anthony E. (US) | 1992-06-03 | — | — | EP | claimed |
| EP-0330685-A1 | CHROMOGENIC COPY SYSTEM AND METHODS | Vassiliades, Anthony E. (US) | 1989-09-06 | — | — | EP | claimed |
| EP-0330685-A4 | CHROMOGENIC COPY SYSTEM AND METHODS. | VASSILIADES ANTHONY E | 1989-08-09 | — | — | EP | claimed |
| WO-1989000506-A1 | CHROMOGENIC COPY SYSTEM AND METHODS | VASSILIADES ANTHONY E (US) | 1989-01-26 | — | — | WO | claimed |
| EP-4388029-A1 | RELEASE LAYER COMPOSITION FOR TRANSFER OF COMPONENTS | Terecircuits Corporation (US) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024049769-A2 | PATTERNED RELEASE LAYERS, AND METHODS OF MAKING AND USING THEM IN DEVICE MANUFACTURING | TERECIRCUITS CORPORATION (US) | 2024-03-07 | — | — | WO | disclosed |
| US-20230130004-A1 | RELEASE LAYER COMPOSITION FOR TRANSFER OF COMPONENTS | TERECIRCUITS CORPORATION | 2023-04-27 | — | — | US | disclosed |
| CN-115803030-A | Compounds and methods for KRAS-targeted degradation | 阿维纳斯企业公司 | 2023-03-14 | — | — | CN | disclosed |
| WO-2023023554-A1 | RELEASE LAYER COMPOSITION FOR TRANSFER OF COMPONENTS | TERECIRCUITS CORPORATION (US) | 2023-02-23 | — | — | WO | disclosed |
| US-11007161-B1 | Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films | MORRISON Eric (US) | 2021-05-18 | — | — | US | disclosed |
| CN-111304964-A | Carbon-free carbon paper color developing agent and preparation process thereof | 浙江长安仁恒科技股份有限公司 | 2020-06-19 | — | — | CN | disclosed |
| US-10596117-B1 | Lipoleosomes as carriers for aromatic amide anesthetic compounds | MORRISON Eric (US) | 2020-03-24 | — | — | US | disclosed |
| EP-0330685-A4 | CHROMOGENIC COPY SYSTEM AND METHODS. | VASSILIADES ANTHONY E | 1989-08-09 | — | — | EP | disclosed |
| WO-1989000506-A1 | CHROMOGENIC COPY SYSTEM AND METHODS | VASSILIADES ANTHONY E (US) | 1989-01-26 | — | — | WO | disclosed |
| WO-1988009365-A1 | DIESEL FUEL COMPOSITION | EXXON CHEMICAL PATENTS, INC. (US) | 1988-12-01 | — | — | WO | disclosed |
| EP-0293192-A1 | Diesel fuel composition | EXXON CHEMICAL PATENTS INC. (US) | 1988-11-30 | — | — | EP | disclosed |
| US-4745026-A | FINE PARTICLE SOLID PLASTICIZER | MITSUBISHI PAPER MILLS, LTD. (JP) | 1988-05-17 | — | — | US | disclosed |
| EP-0264051-A2 | Derivatives of hydroxycarboxylic acids, method for their production and their application to heat and pressure sensitive recording materials | BAYER AG (DE) | 1988-04-20 | — | — | EP | disclosed |
| EP-0239444-A1 | Ferroelectric liquid crystal, process for its manufacture and its use in a liquid-crystal mixture | THOMSON-CSF (FR) | 1987-09-30 | — | — | EP | disclosed |
| US-4518807-A | OIL ADDITIVES | MARUZEN OIL CO., LTD. (JP) | 1985-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11007161-B1 | Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films | AHR, ARNT, SULT2A1 | KMT2A 2927/4885MEN1 4315/4885LMNA 2834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.